DePuy Revision TKA Implant 5yr Survivorship
|ClinicalTrials.gov Identifier: NCT01245478|
Recruitment Status : Withdrawn (Retrospective record review only (no subject enrollment). Contract never executed between Sponsor and Site.)
First Posted : November 22, 2010
Last Update Posted : May 1, 2013
This will be a retrospective chart review of 200 charts of adult patients who have undergone a revision TKA at New England Baptist Hospital and who received implant component(s) manufactured by DePuy Orthopedics. The data will be collected retrospectively after patients are seen clinically for a minimum of five years after surgery to answer:
- What is the five-year survivorship of revision a knee prosthesis containing components manufactured by DePuy Orthopedics among adult revision TKA patients?
- What patient factors are associated with the need for re-operation after revision TKA among patients receiving DePuy implant components? How do clinical outcomes change from baseline over the five-year follow-up after revision TKA surgery?
Data collection will include patient-reported and clinician-reported measures.
|Condition or disease|
|Complications; Arthroplasty, Mechanical|
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Clinical Outcome and 5-year Implant Survival Rate Among Adult Revision Total Knee Arthroplasty Patients With DePuy Implant Components|
|Study Start Date :||November 2010|
|Primary Completion Date :||July 2012|
|Study Completion Date :||July 2012|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01245478
|Principal Investigator:||John Richmond, MD||New England Baptist Hospital|